Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Amati AIM VCT Plc is a venture capital trust that focuses on investing in smaller companies listed on the Alternative Investment Market (AIM) in the United Kingdom. The primary function of Amati AIM VCT Plc is to provide individual investors with an opportunity to tap into the growth potential of emerging enterprises through a tax-efficient structure. By investing in small, dynamic companies, often in the early stages of development, the trust aims to deliver long-term capital appreciation. Amati AIM VCT Plc primarily targets sectors that exhibit strong growth prospects, such as technology, healthcare, and renewable energy. As a venture capital trust, it plays a pivotal role in supporting innovation and entrepreneurship by providing much-needed capital to burgeoning companies that may not have access to traditional funding avenues. In the financial market, Amati AIM VCT Plc contributes to portfolio diversification and enables investors to indirectly participate in the high-risk, high-reward segment of smaller business investments, thereby aiding the broader economic ecosystem and serving as a catalyst for small business development in the UK.
£0.53
+£0.00 (+0.00%)
EOD Jul 3, 2026
Revenue grew 95.0%, still solid.
Negative free cash flow of -£742K. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
-£2M
▲ +95.0% YoY
Net Income (TTM)
-£3M
▲ +93.4% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-£742K
▲ +44.0% YoY
Op. Cash Flow (TTM)
-£742K
▲ +44.0% YoY
Net Debt
-£22M
Net Cash Position
Cash & Equiv.
£22M
Continue Research
Amati AIM VCT (AMAT.XLON)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in .
On quality, Amati AIM VCT scores 10/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 30.6%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Amati AIM VCT scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 3 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Amati AIM VCT pays a regular dividend of about £0.16 per share per year (typically in quarterly installments), a yield of roughly 30.6% at the current price. Amati AIM VCT has grown the dividend at roughly 36.8% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For AMAT.XLON's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. you should weigh AMAT.XLON's valuation and scores 10/100 on quality (lower-quality). It also yields about 30.6%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.